Mayo Clinic neuropathologist Caterina Giannini, M.D., Ph.D., received the American Association of Neuropathologists’ (AANP) award for Meritorious Contributions to Neuropathology during the AANP’s 98th annual meeting in June.
Workforce Stability and Strategies for Retention - Insights
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Jennifer Storlie, operations manager of Inpatient Laboratory Services at Mayo Clinic in Rochester, Minnesota, to talk about workforce stability and strategies...
Register today for Classical Hematology 2023 - Insights
Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference will also provide the latest...
Mayo Clinic Laboratories offers an innovative testing solution for the early detection of Alzheimer's disease. Learn more at the AAIC 2022 tradeshow.
Week in Review: March 3 - Insights
Today's Highlights Include: COVID-19 deaths remain low compared to previous winters, FDA authorizing first at-home combo flu/Covid test, and Rochester public schools evaluating mental health needs and services throughout the district.
Week in Review: February 3 - Insights
Today's Highlights Include: President Biden to End Covid-19 Emergencies On May 11, and Children’s Minnesota Received $3 Million Grant To Address Pediatric Health Disparities.
CPT codes and LOINC update: November 2024 - Insights
This page lists updates posted to Mayo Clinic Labs during the month of November.
Study identifies critical link between inflammation and liver regeneration - Insights
Mayo Clinic researchers and collaborators have discovered a critical role that inflammation plays in liver regeneration after liver resection. While effective regeneration requires some inflammation, too much of it causes regeneration...
Unique collaboration advances discoveries for rare disease - Insights
The nonprofit patient advocacy group called The MOG Project supports patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), which is a rare and debilitating central nervous system demyelinating disorder. A...
Ceramide testing provides algorithmic score for heart attack risk - Insights
Mayo Clinic Laboratories offers a ceremide test to advise patients and their clinicians of the potential risk of heart attack. Using liquid chromatography-mass spectrometry technology, the test renders an algorithmic score after sorting...